The latest news and information about what's going on with SCI science and research.
Wheelzetta, a reader, asks, “How come you don’t write about the trial in China that came out last week, where people with spinal cord injury were walking?”
Well, Wheelz, I think I know what you’re referring to. I saw a piece the other day from the Times of India
by way of Agence France-Presse, with this headline: “Doctor claims breakthrough in race for spinal cord injury ‘cure.' The doctor is Wise Young, who is quoted as saying, “It’s the first time in human history that we can see the regeneration of the spinal cord.” Really? Regeneration? Wow. Read More
So yes, the bladder regeneration paper
this week from the Jerry Silver group did light up some significant media coverage. A number of news reports basically parroted the press release from Case Reserve Western University
, Silver’s homebase.
Here’s a shout out to one reporter, John Mangels, from the local Plain Dealer in Cleveland. He took the time to understand the questions Silver was asking, and the research methods the scientists applied to get the answers. Mangels kept the right context; he didn’t hyperventilate about what a hometown breakthrough this was. Read More
The enzyme chondroitinase
degrades the complex sugar-chains that form scar tissue after nerve trauma. The substance is often mentioned in science articles related to spinal cord injury. Indeed, ‘chase,’ as it is called, was a major factor in the big regenerative story
this week from the Jerry Silver lab showing a strong regenerative response and bladder recovery in animals. Read More
We are going to hear a lot about a new paper from the Jerry Silver at Case Western. Silver
, a former member of the Reeve Science Advisory Council, is a career spinal cord injury investigator. He’s opinionated and can come across as brashly confident, but he is a delightful character and also one of the most optimistic scientists in the field. Read More
You don’t hear so much about olfactory ensheathing glial (OEG) cells these days. These are cells that are harvested from tissue in the nose; they have self-renewing properties and have been shown in numerous animal studies, and a few human trials, to help repair the injured spinal cord. OEG cells have been used clinically in hundreds of patients, in China, and to a lesser degree, in Portugal. Read More
The regulatory equivalents of the FDA in Switzerland, and now Canada, have approved a human neural stem cell trial for people with spinal cord injuries three to 12-months post-injury. The FDA? Well, no, not yet. Read More